Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma

This study has been completed.
Sponsor:
Information provided by:
University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT00116961
First received: June 30, 2005
Last updated: February 5, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)